Key result
Hemagglutinin-negative Coxsackie A21 elicits ~11-fold higher neutralizing antibodies vs the positive variant despite similar illness.
Why the study?
Does inoculation with HA- variant of Coxsackie A21 virus compared to HA+ variant cause differing clinical illness, virus shedding, or antibody responses in healthy volunteers?
Does inoculation with HA- variant of Coxsackie A21 virus compared to HA+ variant cause differing clinical illness, virus shedding, or antibody responses in healthy volunteers?
The HA- variant of Coxsackie A21 virus stimulates a significantly greater antibody response than the HA+ variant despite causing similar clinical illness and viral shedding.
Answers are grounded in this paper and cite their sources.
HA- variant may elicit stronger neutralizing responses in volunteers; leaves open implications for viral attenuation and immunogenicity studies.
Coxsackie A21 virus has been associated with naturally occurring human respiratory illness (1-4), and in this laboratory many of the re- sponses to inoculation with this agent have been studied in volunteers (5,6).In a previous report (7) the recognition and separation of hemagglutinating and nonhemag- glutinating Coxsackie A21 particles were described.Evidence was presented that these were genetic variants distinguishable by differences in their capacity to grow in primary and continuous cell line tissue cultures.Passage in continuous cell lines led to a predominance of hemagglutinin- negative (HA -) particles, whereas passage in primary tissue culture slightly favored growth of hemagglutinin-positive (HA+) particles.To determine whether the HA + and HA - variants of Coxsackie A21 virus caused differing human responses, volunteer inoculations with separated pools of these variants were performed.The results of these inoculations will be described. MethodsPreparation of inocula.The virus used for volunteer inoculations was derived from a throat swab specimen obtained from a Marine recruit with an acute upper respiratory illness (no.48560, Bouma) (7).This strain of Coxsackie An was serologically indistinguish- able from the original Coe strain described by Lennette, Fox, Schmidt, and Culver (1).Virus was initially iso- lated in primary human embryonic kidney (HEK) tis- sue cultures.Separation of the HA + and HApar- ticles was accomplished by differential adsorption on hu- man type 0 erythrocytes at 40 C (7).The separated
No takes yet. Share an insight, caveat, or question.
Lang et al. (1965) studied Healthy volunteers (n=37). Hemagglutinin-negative (HA-) Coxsackie A21 virus vs. Hemagglutinin-positive (HA+) Coxsackie A21 virus was evaluated on Geometric mean neutralizing antibody titer (nasopharyngeal inoculation) (p=<0.01). Inoculation with the hemagglutinin-negative variant of Coxsackie A21 virus elicited significantly higher neutralizing antibody responses compared to the hemagglutinin-positive variant, despite causing similar rates of clinical illness.
Synapse has enriched 10 related papers. Consider them for comparative context: